OKYO Pharma Limited Sponsored ADR (OKYO) Stock Statistics & Valuation Metrics

OKYO Pharma Limited Sponsored ADR has a market cap or net worth of $76.10M. The enterprise value is $56.20T.

Market Cap

$76.10M

Enterprise Value

$56.20T

OKYO Pharma Limited Sponsored ADR has 52,479,527 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

52,479,527

Owned by Insiders

21.11%

Owned by Institutions

10.88%

OKYO Pharma Limited Sponsored ADR’s return on equity (ROE) is -0.73 and return on invested capital (ROIC) is -68.91%.

Return on Equity (ROE)

-0.73

Return on Assets (ROA)

-0.43

Return on Invested Capital (ROIC)

-68.91%

Return on Capital Employed (ROCE)

-0.69

Revenue Per Employee

0

Profits Per Employee

-1.79M

Employee Count

5

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of OKYO Pharma Limited Sponsored ADR is -5.98. OKYO Pharma Limited Sponsored ADR’s PEG ratio is 0.05.

PE Ratio

-5.98

PS Ratio

0.00

PB Ratio

4.33

Price to FCF

-12.63

Price to Operating Cash Flow

-9.01

PEG Ratio

0.05

In the last 12 months, OKYO Pharma Limited Sponsored ADR had revenue of 0 and earned -8.95M in profits. Earnings per share was -0.24.

Revenue

0

Gross Profit

-6.69M

Operating Income

-8.50M

Pretax Income

-8.94M

Net Income

-8.95M

EBITDA

-8.47M

Earnings Per Share (EPS)

-0.24

In the last 12 months, operating cash flow was -5.94M and capital expenditures -6,080, giving a free cash flow of -5.94M billion.

Operating Cash Flow

-5.94M

Free Cash Flow

-5.94M

Free Cash Flow per Share

-0.16

OKYO Pharma Limited Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-8.09%

Earnings Yield

-17.10%

Beta

0.23

52-Week Price Change

-44.36%

50-Day Moving Average

1.44

200-Day Moving Average

1.60

Relative Strength Index (RSI)

48.43

Average Volume (3m)

67.96K

OKYO Pharma Limited Sponsored ADR upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date

Aug 05, 2025

Next Earnings Date

―

Ex-Dividend Date

―

OKYO Pharma Limited Sponsored ADR as a current ratio of 2.43, with Debt / Equity ratio of 0.00%

Current Ratio

2.43

Quick Ratio

2.43

Debt to Market Cap

0.00

Net Debt to EBITDA

1.72

Interest Coverage Ratio

-17.93

In the past 12 months, OKYO Pharma Limited Sponsored ADR has paid 7,987 in taxes.

Income Tax

7,987

Effective Tax Rate

-0.00

OKYO Pharma Limited Sponsored ADR EV to EBITDA ratio is -6.40, with an EV/FCF ratio of -9.91.

EV to Sales

0.00

EV to EBITDA

-6.40

EV to Free Cash Flow

-9.91

EV to Operating Cash Flow

-9.92

OKYO Pharma Limited Sponsored ADR has $20.59M in cash and marketable securities with $0.00 in debt, giving a net cash position of $20.59M billion.

Cash & Marketable Securities

$20.59M

Total Debt

$0.00

Net Cash

$20.59M

Net Cash Per Share

$0.39

Tangible Book Value Per Share

$0.33

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin

0.00%

Operating Margin

0.00%

Pretax Margin

0.00%

Net Profit Margin

0.00%

EBITDA Margin

0.00%

EBIT Margin

0.00%

The average price target for OKYO Pharma Limited Sponsored ADR is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$6.00

Price Target Upside

319.58% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

―

EPS Growth Forecast

-39.90%

Smart Score

2

AI Score

43